Amersham merger creates world leader
Wednesday 02 July 1997
The new company, Nycomed Amersham, which at yesterday's share prices is valued at over pounds 2bn, will have combined sales of pounds 1.5bn and operating profits of pounds 244m, of which pounds 90m is accounted for by Amersham. The all- paper deal takes the form of an offer for Nycomed by higher rated Amersham - which will leave Amersham shareholders with 47 per cent of the combined group.
Though shares in both Amersham and Nycomed gained strongly in early trading, concerns that annual cost savings will be eroded by fierce competition in Nycomed's core US X-ray imaging market and uncertainty over renewal of two key contracts tempered Amersham's initial 255p hike. Amersham's shares closed 87.5p higher at pounds 16.82p while Nycomed's shares climbed 23 per cent to 132.5 kronas.
Bill Castell, Amersham's chief executive who becomes chief executive of the new group, said Nycomed added potentially exciting areas of MRI and Ultrasound imaging to its own world-leading position in the radioactive sector. "We now have the clout to offer radiological departments an entire range of products," he added. Trond Jacobsen, a director of Nycomed, estimated that the market for Ultrasound imaging agents could be worth pounds 1bn by 2001. "There is a wonderful base of equipment which can use our agents. Most doctors already have ultrasound machines."
The new group will have 30 per cent of the pounds 3bn world imaging market, leading Bracco (half-owned by Germany's Merck) with 21 per cent, the US's Mallinckrodt with 15 per cent and Germany's Schering with 14 per cent.
Mr Castell said that Nycomed's investments in Shanghai and Latin America positioned the enlarged company in new and fast growing markets. Merging administration, sales and marketing and the loss of around 300 jobs, including around 100 from the UK, from a combined workforce of 11,600 offered scope to save at least pounds 40m a year to 2000, with half realised by December next year. Amersham, which is changing its year end from March to December, will make a pounds 50m exceptional provision in its next nine month figures and is also paying a special dividend to Nycomed shareholders.
Analysts agreed that the deal made strategic sense and would be earnings enhancing, though numbers were complicated by the change in year end, pounds 80m cost savings from restructuring at Nycomed following last year's profits warning and the inclusion of the Pharmacia business.
Nigel Barnes, pharmaceutical analyst at Merrill Lynch, said: "This makes an enormous amount of sense given both companies are in the imaging markets. There are synergies too though not great overlap since the new group will be in four different imaging markets." James Dodwell at BZW expects the merger to add around 85p to earnings and is looking for 105p earnings and pre-tax profits of pounds 240m for the year to December 1998.
However, several analysts said privately that competition in Nycomed's mature X-ray imaging business - over 80 per cent of its pounds 154m profits last year - could erode cost savings. Following its blocked merger with generic drug group Ivax last year, Nycomed lost share to rivals who were discounting prices by up to 60 per cent.
Though Mr Jacobsen said that the discounting is levelling off, the key test will be whether, or on what terms, two of Nycomed's US contracts worth 15 per cent of Nycomed's sales are renewed.
There were also concerns that following the merger some 88 per cent of the group's profits will be earned overseas. The group, which is considering paying foreign income dividends, said that if sterling continued at current levels, pro-forma profits would be cut by pounds 30m.
Returning to the stage after 20 years makes actress feel 'nauseous'
Top conservatoire offers ‘groundbreaking’ arts degree
- 1 Scottish independence: Ireland since 1919 is a lesson for Scotland in what a Yes vote means
- 2 A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
- 3 Grandmas keep accidentally tagging themselves as Grandmaster Flash on Facebook
- 4 Daniele Watts: Django Unchained actress detained by Los Angeles police after being mistaken for a prostitute
- 5 Kanye West stops concert after two fans don't stand up - doesn't realise one is in wheelchair and the other disabled
Islamic State: Pope is 'being targeted by Isis', Iraqi ambassador to the Holy See warns
Jennifer Lawrence and Kate Upton nude pictures exhibition cancelled after artist concedes photos were 'stolen property'
Scottish independence referendum: A nation divided against itself
John Travolta addresses former pilot's gay romance allegations publicly for the first time: 'That was the lowest I'd ever felt'
Richard III: Two years after his body was found scientists discover how he died
Daniele Watts: Django Unchained actress detained by Los Angeles police after being mistaken for a prostitute
The political class is doing what Hitler couldn’t – destroying Britain
Scottish independence: Nationalist leader Jim Sillars threatens pro-union companies with 'day of reckoning' after independence
Scottish independence: Yes campaign feels the heat as Alex Salmond's NHS claims come under furious attack
Portuguese academic says British are 'filthy, violent and drunk'
£23m Birmingham cycle scheme is attacked by Tory councillor for not catering to the elderly
iJobs Money & Business
£20000 - £25000 per annum + OTE £35,000 first year: SThree: The SThree group i...
£20 - 24k (Uncapped Commission - £35k Year 1 OTE): Guru Careers: We are seekin...
£20 - 24k + Benefits: Guru Careers: This is a great opportunity for an enthusi...
£280 - £320 per day: Ashdown Group: The Ashdown Group have been engaged by a l...